RecruitingNot ApplicableNCT07335354

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Breast Reconstruction Decision Aid (RECONJOINT)

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

131 participants

Start Date

Jan 5, 2026

Study Type

INTERVENTIONAL

Conditions

Breast Cancer

Summary

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a decision-support tool to help women considering breast reconstruction after mastectomy make informed choices. Researchers want to know if the tool improves decision-making satisfaction and reduces decisional conflict. **You may be eligible if...** - You are 18 or older - You are female - You have a genetic predisposition to breast cancer, or have been diagnosed with ductal carcinoma in situ (DCIS) or invasive breast cancer - You are considering post-mastectomy breast reconstruction - You have a scheduled appointment with a plastic surgery provider (for the randomized trial portion) **You may NOT be eligible if...** - You have recurrent or metastatic breast cancer - You are not considering post-mastectomy breast reconstruction - You are not proficient in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRECONJOINT

RECONJOINT is a Breast Reconstruction Decision Aid

Locations(8)

Memorial Sloan Kettering Basking Ridge

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen

Montvale, New Jersey, United States

Memorial Sloan Kettering Commack

Commack, New York, United States

Memorial Sloan Kettering Westchester

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Memorial Sloan Kettering Nassau

Rockville Centre, New York, United States

Duke Cancer Institute (Data collection only)

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07335354

Related Trials

Genomic Services Research Program

NCT025959571 location

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

NCT052833304 locations

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT068852031 location

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NCT06103864316 locations